Skip to main content
Colorectal Cancer Alliance
  • Helpline (877) 422 2030
  • Screening Quiz
  • My BlueHQ
  • About Us
    • The basics: what is colorectal cancer?
      • Colorectal cancer symptoms
      • Facts and statistics
      • Stages of colorectal cancer
      • Health equity
      • Glossary
      male patient with doctor in office
      What to know
      Knowing your biomarker status informs the most effective treatment plan
    • Screening & prevention: why, when, how?
      • Get screened at 45
      • How to talk to your doctor about screening
      • Colonoscopy prep tips
      • Screening methods
      • Prevention
      two people looking at phone together
      Get Screened
      Take our free screening quiz for personalized recommendations
    • Treatment: what are your options?
      For you
      • Patients
      • Survivors
      • Caregivers
      • Newly diagnosed
      Types of Treatment
      • Surgery
      • Chemo, radiation, and other therapies
      • Clinical trials
      • Why biomarkers matter
      • Colostomy and ileostomy
      • Side effects
      Latina woman with male doctor
      RESOURCES FOR YOU
      10 questions to ask your doctor when newly diagnosed
    • Resources & Support
      Resources
      • BlueHQ patient support hub
      • Live navigator helpline
      • Financial assistance
      • Living well with colorectal cancer
      • Palliative care
      • Hospice
      • Resource library
      Community Support
      • Online communities
      • Buddy Program
      • Young-onset support
      • Stories of hope
      • Community chat
      Dressy couple posing for selfie
      YOUR PATIENT PORTAL
      Personalized resources are ready for you on BlueHQ
    • Research: investments and influence to cure CRC
      • Need for research innovation
      • Plan to cure CRC
      • Apply for a research grant
      • Research funded by Project Cure CRC
      Project Cure Summit audience 2024
      Project Cure CRC
      Learn about our effort to fund expedited and novel cancer research
    • Get involved: help us end colorectal cancer
      Events
      • Walk to End Colon Cancer
      • Attend a Blue Hope Bash
      • Create your own event
      • View all events
      Give
      • Donate now
      • Planned Giving
      • Honor a loved one
      • Start your own fundraiser
      • Shop the Alliance store
      • Other ways to give
      Advocate
      • Volunteer
      • Become an advocate
      • Colorectal Cancer Awareness Month
      • Partner with us
    Colorectal Cancer Alliance
      • The basics: what is colorectal cancer?
        • Colorectal cancer symptoms
        • Facts and statistics
        • Stages of colorectal cancer
        • Health equity
        • Glossary
        male patient with doctor in office
        What to know
        Knowing your biomarker status informs the most effective treatment plan
      • Screening & prevention: why, when, how?
        • Get screened at 45
        • How to talk to your doctor about screening
        • Colonoscopy prep tips
        • Screening methods
        • Prevention
        two people looking at phone together
        Get Screened
        Take our free screening quiz for personalized recommendations
      • Treatment: what are your options?
      • For you
        • Patients
        • Survivors
        • Caregivers
        • Newly diagnosed
        Types of Treatment
        • Surgery
        • Chemo, radiation, and other therapies
        • Clinical trials
        • Why biomarkers matter
        • Colostomy and ileostomy
        • Side effects
        Latina woman with male doctor
        RESOURCES FOR YOU
        10 questions to ask your doctor when newly diagnosed
      • Resources & Support
      • Resources
        • BlueHQ patient support hub
        • Live navigator helpline
        • Financial assistance
        • Living well with colorectal cancer
        • Palliative care
        • Hospice
        • Resource library
        Community Support
        • Online communities
        • Buddy Program
        • Young-onset support
        • Stories of hope
        • Community chat
        Dressy couple posing for selfie
        YOUR PATIENT PORTAL
        Personalized resources are ready for you on BlueHQ
      • Research: investments and influence to cure CRC
        • Need for research innovation
        • Plan to cure CRC
        • Apply for a research grant
        • Research funded by Project Cure CRC
        Project Cure Summit audience 2024
        Project Cure CRC
        Learn about our effort to fund expedited and novel cancer research
      • Get involved: help us end colorectal cancer
      • Events
        • Walk to End Colon Cancer
        • Attend a Blue Hope Bash
        • Create your own event
        • View all events
        Give
        • Donate now
        • Planned Giving
        • Honor a loved one
        • Start your own fundraiser
        • Shop the Alliance store
        • Other ways to give
        Advocate
        • Volunteer
        • Become an advocate
        • Colorectal Cancer Awareness Month
        • Partner with us
    • You don't have to do this alone. Call our toll-free helpline: (877) 422-2030

    • Quick Links
      • About us
      • Mission and goals
      • Financial information
      • Our team
      • Board of Directors
      • Careers
      • Sponsorship
      • News
      • For media
      • Contact us
      Alliance Sites
      • LEAD FROM BEHIND
      • BlueHQ patient support hub
      • Alliance shop
    • Home
    • Resources & Support
      • Resources
      • BlueHQ patient support hub
      • Live navigator helpline
      • Financial assistance
      • Living well with colorectal cancer
      • Palliative care
      • Hospice
      • Resource library
      • Community Support
      • Online communities
      • Buddy Program
      • Young-onset support
      • Stories of hope
      • Community chat

    Colorectal cancer resource library

    • Share with Email
    Type
    Topics
    Audiences

    Showing 21–39 of 39 results

    Filtered By:
    Your search did not return any results. Please try another search.
    Study: Signatera Can Help Predict Recurrence After Colorectal Cancer Surgery
    Blog

    Study: Signatera can help predict recurrence after colorectal cancer surgery

    This information can help oncologists predict who is likely to benefit from chemotherapy after surgery, which is called adjuvant chemotherapy.

    Jan 24, 2023
    First FDA-Approved Treatment for HER2-Positive Colorectal Cancer
    Blog

    First FDA-approved treatment for HER2-positive colorectal cancer

    “Historically, patients with HER2-positive metastatic colorectal cancer who have progressed following frontline therapy have had poor outcomes,” said John Strickler, M.D. and lead investigator of the MOUNTAINEER trial. “The FDA approval of a chemotherapy-free combination regimen that specifically targets HER2 is great news for these patients.”

    Jan 20, 2023
    Michelle Cappel: Biomarker testing extends life
    Blog

    Michelle Cappel: Biomarker testing extends life

    Michelle Cappel owes a lot to colorectal cancer biomarker testing — seven years of life and counting.

    Jan 8, 2024
    FDA Approves FRUZAQLA for Previously Treated mCRC
    Blog

    FDA approves FRUZAQLA for previously treated mCRC

    Takeda has announced U.S. Food and Drug Administration (FDA) approval of FRUZAQLA (fruquintinib), an oral targeted therapy for adults with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy.

    Nov 9, 2023
    Blog

    Why the doctors chose robotic-assisted surgery

    In the case of Dr. Paul O'Rourke – a 39-year-old, stage I rectal cancer survivor, and physician at Johns Hopkins – robotic-assisted surgery (RAS) was the surgical option he was fortunate he had.

    Aug 17, 2023
    Lillian Abreu: Learning About Follow-Up Treatment as a Survivor
    Blog

    Lillian Abreu: Learning about follow-up treatment as a survivor

    Lillian Abreu was thirty years old and five months pregnant when she found out she had stage I colon cancer. Thankfully, she was able to immediately undergo a right hemicolectomy without further complication to her or her baby.

    Aug 7, 2023
    FDA Approves Lonsurf In Combination With Bevacizumab for Metastatic Colorectal Cancer Patients
    Blog

    FDA approves lonsurf in combination with bevacizumab for metastatic colorectal cancer patients

    Taiho Oncology and Taiho Pharmaceutical have announced U.S. Food and Drug Administration (FDA) approval of Lonsurf alone or in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have undergone two prior regimens of treatment.

    Aug 3, 2023
    Christy Williams, a mom and colorectal cancer survivor, plays a table-top game with her family.
    Blog

    Christy Williams: Biomarker testing leads to successful treatment

    Statistics suggested that Christy’s odds of survival were grim, so she leaned into her faith and kept a positive outlook. She tried to control what she could. And, critically, she received biomarker testing.

    Apr 21, 2024
    Clinical Trial To Evaluate Onvansertib as First-Line mCRC Treatment
    Blog

    Clinical trial to evaluate onvansertib as first-line mCRC treatment

    People with RAS-mutated metastatic colorectal cancer (mCRC) have seen little progress in first-line treatment options over the past two decades, but that could soon change for thousands of new patients, according to a press release from Cardiff Oncology.

    Aug 16, 2023
    A sign at the BMS headquarters
    Blog

    Krazati approved for previously treated KRASG12C colorectal cancer

    The treatment option is for patients with KRASG12C-mutated locally advanced or metastatic colorectal cancer (CRC) who have received prior treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.

    Jun 25, 2024
    Don Shippey: From Stage IV to Six Years Cancer-Free After Receiving HAI Pump
    Blog

    Don Shippey: from stage IV to six years cancer-free after receiving HAI pump

    Don Shippey was 55 years old in 2016 when he decided he’d been putting off his colonoscopy long enough.

    Nov 15, 2023
    The AllyCon thrive logo.
    Blog

    Watch session videos from AllyCon 2024

    Watch videos of two major general sessions from AllyCon 2024, the Alliance's patient support conference, which took place in Miami Beach in December.

    Jan 8, 2025
    Amgen's headquarters
    Blog

    Treatment for KRAS G12C-mutated metastatic CRC approved by FDA

    The U.S. Food and Drug Administration has approved sotorasib in combination with panitumumab for the treatment of adult patients with KRAS G12C-mutated metastatic colorectal cancer.

    Jan 17, 2025
    Hope performing a yoga pose
    Blog

    HAI liver pump for mCRC offers second chances

    Discover how Hope overcame stage IV colorectal cancer with an innovative HAI liver pump, staying active and proving that second chances are possible.

    Jan 27, 2025
    A photograph of Lexie in a chemotherapy chair.
    Blog

    Lexie Haglund: Beating stage IV CRC

    Discover how knowing her G12C biomarker guided Lexie’s stage IV colorectal cancer treatment — from a shock diagnosis to HIPEC surgery — and why screening, research, and self-advocacy matter.

    Feb 26, 2025
    TIL liver mets
    Blog

    NIH: Combination immunotherapy shrank GI cancers

    A new kind of tumor infiltrating lymphocyte (TIL) therapy improved the treatment’s effectiveness in patients with metastatic GI cancers.

    Apr 1, 2025
    An image of the exterior of the U.S. Capitol Building
    Blog

    EPIC Act to Advance New CRC Therapies Needs Support

    The EPIC Act would encourage investment in clinical trials for additional uses of existing drugs.

    Mar 25, 2024
    Blog

    FDA approves new treatment for metastatic CRC with BRAF mutation

    The U.S. Food and Drug Administration has approved encorafenib (marketed as BRAFTOVI) in combination with cetuximab (marketed as ERBITUX) as a second-line therapy for the treatment of adult patients with metastatic colorectal cancer with a BRAFV600E mutation.

    Apr 22, 2020
    The main corridor at the 2025 ASCO Annual Meeting
    Blog

    2025 ASCO update: Six big studies

    The 2025 ASCO Annual Meeting featured several important studies that could change how colorectal cancer is treated, including a pivotal study for BRAF V600E patients.

    Jun 24, 2025
    Page 1 Page 2
    BlueHQ

    Sign up for BlueHQ

    BlueHQ.org is the Colorectal Cancer Alliance's online patient support hub. Access personalized resources, tools, and community.

    support group three people

    Get connected with your allies

    There are many ways to find your community through the Alliance. Try one of our online communities.

    Learn More

    You don't have to do this alone. Call our toll-free helpline: (877) 422-2030

    Colorectal Cancer Alliance
    • FACEBOOK
    • INSTAGRAM
    • LINKEDIN
    • TWITTER-X
    • TIKTOK
    • YOUTUBE
    Sign up for life-saving updates and alerts
    CAPTCHA

    Sign up for text updates. By participating, you agree to the terms & privacy policy for autodialed recurring donation messages from Colorectal Cancer Alliance to the phone number you provide. No consent required to buy. Text STOP to end. Msg&data rates may apply.

    Quick Links
    • About us
    • Mission and goals
    • Financial information
    • Our team
    • Board of Directors
    • Careers
    • Sponsorship
    • News
    • For media
    • Contact us
    Get Involved
    • Donate
    • Colorectal Cancer Awareness Month
    • All events
    • Join us to receive updates
    Alliance Sites
    • LEAD FROM BEHIND
    • BlueHQ patient support hub
    • Alliance shop

    1025 Vermont Ave NW, Suite 1066. Washington, DC 20005

    © 2025 Colorectal Cancer Alliance. 501(c)(3) tax-exempt organization. Tax ID Number: 86-0947831

    • Disclaimer
    • Privacy policy
    • Non-discrimination statement
    • Do not sell or share my personal data
    Charity Navigator
    GuideStar